|
1
|
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.
|
Lancet
|
2008
|
12.59
|
|
2
|
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.
|
Blood
|
2010
|
4.17
|
|
3
|
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.
|
Blood
|
2003
|
3.88
|
|
4
|
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
|
Gut
|
2011
|
3.81
|
|
5
|
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.
|
Cancer Res
|
2007
|
3.19
|
|
6
|
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
|
Haematologica
|
2005
|
3.11
|
|
7
|
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.
|
Exp Hematol
|
2004
|
2.81
|
|
8
|
Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation.
|
Blood
|
2007
|
2.55
|
|
9
|
Imatinib for refractory chronic graft-versus-host disease with fibrotic features.
|
Blood
|
2009
|
2.51
|
|
10
|
Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study.
|
Clin Immunol
|
2007
|
2.38
|
|
11
|
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
|
Blood
|
2008
|
2.35
|
|
12
|
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor.
|
Blood
|
2008
|
2.34
|
|
13
|
Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations.
|
Haematologica
|
2007
|
2.23
|
|
14
|
Atypical features of familial hemophagocytic lymphohistiocytosis.
|
Blood
|
2004
|
2.21
|
|
15
|
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.
|
Blood
|
2011
|
2.18
|
|
16
|
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia.
|
Blood
|
2009
|
2.15
|
|
17
|
Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.
|
Blood
|
2013
|
2.12
|
|
18
|
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
|
J Clin Oncol
|
2005
|
2.10
|
|
19
|
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group.
|
Blood
|
2009
|
2.06
|
|
20
|
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.
|
Blood
|
2008
|
1.96
|
|
21
|
Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
|
Haematologica
|
2002
|
1.91
|
|
22
|
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?
|
Blood
|
2011
|
1.78
|
|
23
|
Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
|
Haematologica
|
2008
|
1.78
|
|
24
|
Mesenchymal stromal cells.
|
Ann N Y Acad Sci
|
2009
|
1.76
|
|
25
|
Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma.
|
N Engl J Med
|
2004
|
1.72
|
|
26
|
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.
|
Haematologica
|
2010
|
1.68
|
|
27
|
Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets.
|
Blood
|
2007
|
1.67
|
|
28
|
Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis.
|
Br J Haematol
|
2005
|
1.64
|
|
29
|
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia.
|
Blood
|
2007
|
1.61
|
|
30
|
Rituximab for the treatment of refractory autoimmune hemolytic anemia in children.
|
Blood
|
2003
|
1.58
|
|
31
|
Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes.
|
Biol Blood Marrow Transplant
|
2005
|
1.58
|
|
32
|
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.
|
J Clin Oncol
|
2005
|
1.58
|
|
33
|
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.
|
Blood
|
2010
|
1.56
|
|
34
|
Ethical reappraisal of 15 years of cord-blood transplantation.
|
Lancet
|
2003
|
1.55
|
|
35
|
A proportion of patients with lymphoma may harbor mutations of the perforin gene.
|
Blood
|
2005
|
1.54
|
|
36
|
Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor.
|
Cytotherapy
|
2011
|
1.54
|
|
37
|
Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.
|
Haematologica
|
2005
|
1.51
|
|
38
|
Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease.
|
Haematologica
|
2003
|
1.51
|
|
39
|
Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication.
|
Blood
|
2002
|
1.50
|
|
40
|
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis.
|
Blood
|
2003
|
1.49
|
|
41
|
Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
|
Immunol Rev
|
2008
|
1.47
|
|
42
|
SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
|
Blood
|
2005
|
1.44
|
|
43
|
Human hepatic stellate cells are liver-resident antigen-presenting cells.
|
Hepatology
|
2011
|
1.42
|
|
44
|
Congenital aggressive variant of Langerhans cells histiocytosis with CD56+/E-Cadherin- phenotype.
|
Pediatr Blood Cancer
|
2009
|
1.42
|
|
45
|
Treatment with short-term, high-dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpura.
|
Br J Haematol
|
2003
|
1.42
|
|
46
|
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation.
|
Blood
|
2003
|
1.40
|
|
47
|
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study.
|
Haematologica
|
2005
|
1.40
|
|
48
|
Familial haemophagocytic lymphohistiocytosis: survival of a premature twin with immuno-chemotherapy and bone marrow transplantation from an HLA-identical unrelated donor.
|
Acta Paediatr
|
2005
|
1.39
|
|
49
|
Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.
|
Blood
|
2012
|
1.37
|
|
50
|
Systematic identification of edited microRNAs in the human brain.
|
Genome Res
|
2012
|
1.35
|
|
51
|
Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome.
|
Blood
|
2002
|
1.34
|
|
52
|
Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease.
|
Br J Haematol
|
2013
|
1.31
|
|
53
|
Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia.
|
Blood
|
2013
|
1.29
|
|
54
|
CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype.
|
Blood
|
2013
|
1.28
|
|
55
|
Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes.
|
Blood
|
2002
|
1.28
|
|
56
|
Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia.
|
J Clin Oncol
|
2010
|
1.25
|
|
57
|
Somatic PTPN11 mutations in childhood acute myeloid leukaemia.
|
Br J Haematol
|
2005
|
1.25
|
|
58
|
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.
|
Blood
|
2007
|
1.23
|
|
59
|
Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
|
Am J Hematol
|
2007
|
1.22
|
|
60
|
Polyomavirus BK-specific immunity after kidney transplantation.
|
Transplantation
|
2004
|
1.22
|
|
61
|
Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction.
|
Blood
|
2005
|
1.20
|
|
62
|
A-to-I RNA editing: the "ADAR" side of human cancer.
|
Semin Cell Dev Biol
|
2011
|
1.19
|
|
63
|
Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
|
Biol Blood Marrow Transplant
|
2007
|
1.19
|
|
64
|
Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
|
Ann N Y Acad Sci
|
2005
|
1.18
|
|
65
|
Ex vivo expansion of mesenchymal stromal cells.
|
Best Pract Res Clin Haematol
|
2011
|
1.18
|
|
66
|
Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation.
|
Nephrol Dial Transplant
|
2007
|
1.17
|
|
67
|
Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing.
|
Cancer Res
|
2011
|
1.16
|
|
68
|
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment.
|
Blood
|
2009
|
1.15
|
|
69
|
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
|
Br J Haematol
|
2002
|
1.15
|
|
70
|
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype.
|
Blood
|
2005
|
1.14
|
|
71
|
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy.
|
Curr Pharm Des
|
2013
|
1.13
|
|
72
|
Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).
|
Haematologica
|
2008
|
1.12
|
|
73
|
Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.
|
Blood
|
2011
|
1.12
|
|
74
|
Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
|
J Immunol
|
2014
|
1.12
|
|
75
|
GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children.
|
Blood
|
2005
|
1.11
|
|
76
|
Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors.
|
Haematologica
|
2009
|
1.10
|
|
77
|
Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia.
|
Haematologica
|
2010
|
1.09
|
|
78
|
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
|
J Clin Oncol
|
2008
|
1.09
|
|
79
|
ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1.
|
Biol Rev Camb Philos Soc
|
2011
|
1.09
|
|
80
|
Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations.
|
Blood
|
2008
|
1.07
|
|
81
|
Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients.
|
Transfusion
|
2010
|
1.06
|
|
82
|
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group.
|
Br J Haematol
|
2002
|
1.06
|
|
83
|
Adolescents with cancer in Italy: entry into the national cooperative paediatric oncology group AIEOP trials.
|
Eur J Cancer
|
2009
|
1.06
|
|
84
|
Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome.
|
Blood
|
2010
|
1.05
|
|
85
|
Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice.
|
Clin Cancer Res
|
2012
|
1.05
|
|
86
|
Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behcet disease.
|
Blood
|
2004
|
1.05
|
|
87
|
Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants.
|
Blood
|
2006
|
1.04
|
|
88
|
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML.
|
Blood
|
2012
|
1.04
|
|
89
|
Survival of children with cancer in Italy, 1989-98. A report from the hospital based registry of the Italian Association of Paediatric Haematology and Oncology (AIEOP).
|
Eur J Cancer
|
2008
|
1.03
|
|
90
|
Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapy.
|
Hum Gene Ther
|
2007
|
1.03
|
|
91
|
Human natural killer cells: origin, receptors, function, and clinical applications.
|
Int Arch Allergy Immunol
|
2014
|
1.03
|
|
92
|
Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation.
|
Br J Haematol
|
2003
|
1.03
|
|
93
|
Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: tailoring better vaccination strategies.
|
Eur J Immunol
|
2013
|
1.02
|
|
94
|
Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
|
Clin Infect Dis
|
2009
|
1.02
|
|
95
|
Homozygosity for human leucocyte antigen-C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen-C-matched unrelated donor haematopoietic stem cell transplantation.
|
Br J Haematol
|
2005
|
1.01
|
|
96
|
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.
|
Haematologica
|
2014
|
1.00
|
|
97
|
Neuroblastoma-derived TGF-β1 modulates the chemokine receptor repertoire of human resting NK cells.
|
J Immunol
|
2013
|
1.00
|
|
98
|
Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations.
|
Hum Mutat
|
2010
|
0.99
|
|
99
|
Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
|
Transplantation
|
2006
|
0.99
|
|
100
|
The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies.
|
Br J Haematol
|
2009
|
0.99
|
|
101
|
MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte-macrophage maturation in AML-M5 THP-1 cells.
|
Oncogene
|
2003
|
0.98
|
|
102
|
No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission.
|
Blood
|
2011
|
0.98
|
|
103
|
Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
|
Cancer
|
2002
|
0.97
|
|
104
|
Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia.
|
Blood
|
2006
|
0.97
|
|
105
|
Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia.
|
Br J Haematol
|
2009
|
0.96
|
|
106
|
Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.
|
World J Gastroenterol
|
2011
|
0.96
|
|
107
|
Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.
|
J Clin Oncol
|
2013
|
0.96
|
|
108
|
Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.
|
PLoS One
|
2012
|
0.95
|
|
109
|
Marriage and parenthood among childhood cancer survivors: a report from the Italian AIEOP Off-Therapy Registry.
|
Haematologica
|
2011
|
0.95
|
|
110
|
Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood.
|
Hum Genet
|
2009
|
0.95
|
|
111
|
Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
|
Haematologica
|
2004
|
0.95
|
|
112
|
Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia.
|
Blood
|
2007
|
0.95
|
|
113
|
Multicluster nosocomial outbreak of parainfluenza virus type 3 infection in a pediatric oncohematology unit: a phylogenetic study.
|
Haematologica
|
2009
|
0.95
|
|
114
|
An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy.
|
BMC Infect Dis
|
2014
|
0.94
|
|
115
|
A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
|
Pediatrics
|
2009
|
0.94
|
|
116
|
Extracorporeal membrane oxygenation in pediatric recipients of hematopoietic stem cell transplantation: an updated analysis of the Extracorporeal Life Support Organization experience.
|
Intensive Care Med
|
2014
|
0.94
|
|
117
|
Stem cell transplantation for chronic myeloid leukemia in children.
|
Blood
|
2003
|
0.94
|
|
118
|
B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells.
|
Exp Hematol
|
2005
|
0.94
|
|
119
|
Interleukin-15 favors the expansion of central memory CD8+ T cells in ex vivo generated, antileukemia human cytotoxic T lymphocyte lines.
|
J Immunother
|
2008
|
0.93
|
|
120
|
Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation.
|
Blood
|
2004
|
0.93
|
|
121
|
Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
|
J Pathol
|
2011
|
0.93
|
|
122
|
Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells.
|
Am J Transplant
|
2005
|
0.93
|
|
123
|
Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: experience of two pediatric institutions.
|
Leuk Lymphoma
|
2008
|
0.93
|
|
124
|
Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes.
|
Blood
|
2002
|
0.92
|
|
125
|
Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function.
|
Blood
|
2006
|
0.92
|
|
126
|
First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection.
|
J Clin Virol
|
2010
|
0.92
|
|
127
|
Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4- subset dynamics and correlates with remission state.
|
J Immunol
|
2011
|
0.92
|
|
128
|
Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma.
|
Neuro Oncol
|
2005
|
0.92
|
|
129
|
Bone marrow transplantation for inherited bone marrow failure syndromes.
|
Pediatr Clin North Am
|
2010
|
0.92
|
|
130
|
Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
|
Biol Blood Marrow Transplant
|
2009
|
0.91
|
|
131
|
The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia.
|
Br J Haematol
|
2007
|
0.91
|
|
132
|
Kinetics of Epstein-Barr virus DNA load in different blood compartments of pediatric recipients of T-cell-depleted HLA-haploidentical stem cell transplantation.
|
J Clin Microbiol
|
2008
|
0.91
|
|
133
|
Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7.
|
Blood
|
2003
|
0.91
|
|
134
|
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.
|
Oncotarget
|
2014
|
0.91
|
|
135
|
The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genomic-wide association studies.
|
Autoimmun Rev
|
2012
|
0.90
|
|
136
|
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major.
|
Br J Haematol
|
2008
|
0.90
|
|
137
|
Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT.
|
Blood
|
2010
|
0.90
|
|
138
|
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease.
|
PLoS One
|
2012
|
0.89
|
|
139
|
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.
|
J Transl Med
|
2012
|
0.89
|
|
140
|
Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia.
|
Ann N Y Acad Sci
|
2010
|
0.89
|
|
141
|
Screening of novel genetic aberrations in pediatric acute myeloid leukemia: a report from the AIEOP AML-2002 study group.
|
Blood
|
2012
|
0.89
|
|
142
|
Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients.
|
J Am Soc Nephrol
|
2003
|
0.89
|
|
143
|
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.
|
BMC Med
|
2011
|
0.89
|
|
144
|
T and NK cells: two sides of tumor immunoevasion.
|
J Transl Med
|
2013
|
0.89
|
|
145
|
Outcome of very late relapse in children with acute lymphoblastic leukemia.
|
Haematologica
|
2004
|
0.89
|
|
146
|
Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients.
|
BMC Infect Dis
|
2007
|
0.89
|
|
147
|
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation.
|
Exp Hematol
|
2006
|
0.88
|
|
148
|
Thymic function recovery after unrelated donor cord blood or T-cell depleted HLA-haploidentical stem cell transplantation correlates with leukemia relapse.
|
Front Immunol
|
2013
|
0.88
|
|
149
|
MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality.
|
Mol Cancer
|
2011
|
0.88
|
|
150
|
Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro.
|
Stem Cells Dev
|
2014
|
0.88
|
|
151
|
Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial.
|
Blood
|
2003
|
0.88
|
|
152
|
Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders?
|
Haematologica
|
2007
|
0.87
|
|
153
|
T(reg) cells: collection, processing, storage and clinical use.
|
Pathol Res Pract
|
2011
|
0.87
|
|
154
|
Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.
|
Haematologica
|
2008
|
0.87
|
|
155
|
t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.
|
Haematologica
|
2014
|
0.87
|
|
156
|
Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.
|
Haematologica
|
2013
|
0.87
|
|
157
|
The Yin and Yang of non-neuronal α7-nicotinic receptors in inflammation and autoimmunity.
|
Curr Drug Targets
|
2012
|
0.87
|
|
158
|
Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial.
|
Am J Hematol
|
2007
|
0.87
|
|
159
|
Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
|
Biol Blood Marrow Transplant
|
2007
|
0.87
|
|
160
|
Ewing sarcoma of the bone in children under 6 years of age.
|
PLoS One
|
2013
|
0.86
|
|
161
|
Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma.
|
Int J Mol Sci
|
2013
|
0.86
|
|
162
|
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.
|
Blood
|
2002
|
0.86
|
|
163
|
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia.
|
Oncotarget
|
2013
|
0.86
|
|
164
|
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study.
|
Blood
|
2014
|
0.85
|
|
165
|
Single-cell cloning of human, donor-derived antileukemia T-cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reaction.
|
Cancer Res
|
2006
|
0.85
|
|
166
|
Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation.
|
Blood
|
2003
|
0.85
|
|
167
|
Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features.
|
BMC Cancer
|
2014
|
0.85
|
|
168
|
An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: the Euro-mediterranean ITHANET project.
|
Hemoglobin
|
2009
|
0.85
|
|
169
|
Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia.
|
PLoS One
|
2013
|
0.85
|
|
170
|
Whole transcriptome sequencing of a paediatric case of de novo acute myeloid leukaemia with del(5q) reveals RUNX1-USP42 and PRDM16-SKI fusion transcripts.
|
Br J Haematol
|
2014
|
0.85
|
|
171
|
Hematopoietic stem cell transplantation for children with high-risk acute lymphoblastic leukemia in first complete remission: a report from the AIEOP registry.
|
Haematologica
|
2013
|
0.84
|
|
172
|
ADAR enzyme and miRNA story: a nucleotide that can make the difference.
|
Int J Mol Sci
|
2013
|
0.84
|
|
173
|
IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma.
|
PLoS One
|
2012
|
0.84
|
|
174
|
Hematopoietic stem cell transplantation: 40 years of continuous progress and evolution.
|
Haematologica
|
2008
|
0.84
|
|
175
|
Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.
|
Biol Blood Marrow Transplant
|
2013
|
0.84
|
|
176
|
Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation.
|
J Infect Dis
|
2009
|
0.84
|
|
177
|
Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes.
|
Clin Dev Immunol
|
2012
|
0.84
|
|
178
|
Transplantation in the onco-hematology field: focus on the manipulation of αβ and γδ T cells.
|
Pathol Res Pract
|
2011
|
0.84
|
|
179
|
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.
|
Stem Cells Dev
|
2015
|
0.84
|
|
180
|
Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.
|
Cytotherapy
|
2009
|
0.84
|
|
181
|
T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors.
|
J Immunother
|
2008
|
0.84
|
|
182
|
Human NK receptors: from the molecules to the therapy of high risk leukemias.
|
FEBS Lett
|
2011
|
0.84
|
|
183
|
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.
|
BMC Cancer
|
2014
|
0.83
|
|
184
|
Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency.
|
Pediatr Transplant
|
2008
|
0.83
|
|
185
|
Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer.
|
Int J Mol Sci
|
2012
|
0.83
|
|
186
|
Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases.
|
Genes Chromosomes Cancer
|
2002
|
0.83
|
|
187
|
Adoptive immunotherapy with antigen-specific T cells during extracorporeal membrane oxygenation (ECMO) for adenovirus-related respiratory failure in a child given haploidentical stem cell transplantation.
|
Pediatr Blood Cancer
|
2013
|
0.83
|
|
188
|
EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD.
|
Int J Mol Sci
|
2013
|
0.83
|
|
189
|
Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients.
|
Exp Hematol
|
2010
|
0.82
|
|
190
|
Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process.
|
Transfusion
|
2013
|
0.82
|
|
191
|
Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen.
|
Br J Haematol
|
2002
|
0.82
|
|
192
|
Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells.
|
Molecules
|
2013
|
0.82
|
|
193
|
ADARs and the Balance Game between Virus Infection and Innate Immune Cell Response.
|
Curr Issues Mol Biol
|
2014
|
0.81
|
|
194
|
HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2).
|
Cancer Res
|
2004
|
0.81
|
|
195
|
Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498).
|
Haematologica
|
2008
|
0.81
|
|
196
|
The RNA editing enzymes ADARs: mechanism of action and human disease.
|
Cell Tissue Res
|
2014
|
0.81
|
|
197
|
Is there a role for cytokine-induced killer cells in cancer immunotherapy?
|
Immunotherapy
|
2012
|
0.81
|
|
198
|
Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia.
|
Hum Immunol
|
2011
|
0.81
|
|
199
|
Hematopoietic stem-cell transplantation for the Bernard-Soulier syndrome.
|
Ann Intern Med
|
2003
|
0.81
|
|
200
|
Miniaturized and high-throughput assays for analysis of T-cell immunity specific for opportunistic pathogens and HIV.
|
Clin Vaccine Immunol
|
2014
|
0.81
|
|
201
|
Strategies to harness immunity against infectious pathogens after haploidentical stem cell transplantation.
|
Am J Transl Res
|
2011
|
0.81
|
|
202
|
Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia.
|
Blood
|
2012
|
0.81
|
|
203
|
HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia.
|
Haematologica
|
2008
|
0.81
|
|
204
|
Glutathione S-transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort.
|
Pharmacogenomics
|
2012
|
0.80
|
|
205
|
High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.
|
PLoS One
|
2013
|
0.80
|
|
206
|
Fourth International Workshop on Haploidentical Transplants, Naples, Italy, July 8-10, 2004.
|
Blood Cells Mol Dis
|
2004
|
0.80
|
|
207
|
Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia.
|
Am J Hematol
|
2013
|
0.80
|
|
208
|
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism.
|
Int J Cardiol
|
2012
|
0.80
|
|
209
|
Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm.
|
Br J Haematol
|
2011
|
0.80
|
|
210
|
Clinical grading of oral chronic graft-versus-host disease in 104 consecutive adult patients.
|
Haematologica
|
2005
|
0.80
|
|
211
|
Lymphocyte proliferation specific for recall, CMV and HIV antigens in miniaturized and automated format.
|
J Immunol Methods
|
2012
|
0.80
|
|
212
|
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties.
|
PLoS One
|
2013
|
0.79
|
|
213
|
Extracorporeal membrane oxygenation as a bridge to allogeneic T-cell depleted hematopoietic stem cell transplantation in infants with severe combined immune deficiency: is it feasible?
|
Intensive Care Med
|
2014
|
0.79
|
|
214
|
Sirolimus-related toxicity in stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2005
|
0.79
|
|
215
|
Acute abdomen after allogenic hematopoietic stem cell transplantation.
|
Pediatr Rep
|
2011
|
0.79
|
|
216
|
Monitoring the isochromosome i(7)(q10) in the bone marrow of patients with Shwachman syndrome by real-time quantitative PCR.
|
J Pediatr Hematol Oncol
|
2007
|
0.79
|
|
217
|
The role of reduced intensity preparative regimens in patients with thalassemia given hematopoietic transplantation.
|
Ann N Y Acad Sci
|
2010
|
0.79
|
|
218
|
Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects.
|
Cancer Genet Cytogenet
|
2004
|
0.79
|
|
219
|
ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas.
|
BMC Cancer
|
2013
|
0.79
|
|
220
|
Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: successful outcome without original allograft nephrectomy.
|
Am J Kidney Dis
|
2003
|
0.79
|
|
221
|
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
|
Haematologica
|
2004
|
0.79
|
|
222
|
Ex vivo generation and expansion of anti-tumor cytotoxic T-cell lines derived from patients or their HLA-identical sibling.
|
Int J Cancer
|
2004
|
0.79
|
|
223
|
Processing of hematopoietic stem cells from peripheral blood before cryopreservation: use of a closed automated system.
|
Transfusion
|
2011
|
0.79
|
|
224
|
Successful medical treatment of EBV smooth muscle tumor in a renal transplant recipient.
|
Pediatr Transplant
|
2010
|
0.79
|
|
225
|
Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
|
Biol Blood Marrow Transplant
|
2011
|
0.79
|
|
226
|
Cord blood transplantation in children with haematological malignancies.
|
Best Pract Res Clin Haematol
|
2010
|
0.79
|
|
227
|
Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease.
|
J Pediatr Gastroenterol Nutr
|
2013
|
0.79
|
|
228
|
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.
|
Haematologica
|
2006
|
0.79
|
|
229
|
Modified chop-chemotherapy plus rituximab for diffuse large b-cell lymphoma complicating ataxia-telangiectasia.
|
Br J Haematol
|
2003
|
0.79
|
|
230
|
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.
|
Int J Hematol
|
2006
|
0.78
|
|
231
|
Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic zygomycosis in a patient with haematological malignancy.
|
Mycoses
|
2009
|
0.78
|
|
232
|
ERAAP modulation: A possible novel strategy for cancer immunotherapy?
|
Oncoimmunology
|
2012
|
0.78
|
|
233
|
Overview of T-cell depletion in haploidentical stem cell transplantation.
|
Blood Transfus
|
2012
|
0.78
|
|
234
|
Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
|
Genes Chromosomes Cancer
|
2004
|
0.78
|
|
235
|
Insulin resistance in children and adolescents after bone marrow transplantation for malignancies.
|
Haematologica
|
2006
|
0.78
|
|
236
|
The strange case of the lost NRAS mutation in a child with juvenile myelomonocytic leukemia.
|
Pediatr Blood Cancer
|
2011
|
0.78
|
|
237
|
Tetralogy of fallot is an uncommon manifestation of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome.
|
J Pediatr
|
2012
|
0.78
|
|
238
|
Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
|
Exp Hematol
|
2006
|
0.78
|
|
239
|
Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts.
|
J Transl Med
|
2014
|
0.78
|
|
240
|
Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus.
|
J Antimicrob Chemother
|
2009
|
0.78
|
|
241
|
Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
|
Biol Blood Marrow Transplant
|
2009
|
0.78
|
|
242
|
On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies.
|
Clin Immunol
|
2010
|
0.78
|
|
243
|
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors.
|
Hematology
|
2006
|
0.78
|
|
244
|
Unmanipulated donor lymphocytes for EBV-related PTLD after T-cell depleted HLA-haploidentical transplantation.
|
Pediatrics
|
2011
|
0.78
|
|
245
|
Generation and ex vivo expansion of cytotoxic T lymphocytes directed toward different types of leukemia or myelodysplastic cells using both HLA-matched and partially matched donors.
|
Exp Hematol
|
2003
|
0.78
|
|
246
|
Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
|
Med Pediatr Oncol
|
2002
|
0.77
|
|
247
|
Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.
|
Eur J Cancer
|
2010
|
0.77
|
|
248
|
Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation.
|
Haematologica
|
2005
|
0.77
|
|
249
|
Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.
|
Br J Haematol
|
2014
|
0.77
|
|
250
|
Immune reconstitution and early infectious complications following nonmyeloablative hematopoietic stem cell transplantation.
|
Hematology
|
2003
|
0.77
|
|
251
|
Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting.
|
J Pediatr Hematol Oncol
|
2009
|
0.77
|
|
252
|
DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study.
|
Haematologica
|
2011
|
0.77
|
|
253
|
Adoptive Transfer of Herpesvirusspecific Cytotoxic T Lymphocytes in Transplant Recipients.
|
Herpes
|
2000
|
0.77
|
|
254
|
Notch signaling in pediatric soft tissue sarcomas.
|
BMC Med
|
2012
|
0.77
|
|
255
|
Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO).
|
Haematologica
|
2002
|
0.77
|
|
256
|
Treatment of severe refractory acute graft-versus-host disease of the gastrointestinal tract with Campath-1H.
|
Biol Blood Marrow Transplant
|
2005
|
0.77
|
|
257
|
Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.
|
Leuk Lymphoma
|
2014
|
0.77
|
|
258
|
Cord blood transplantation in patients with hemoglobinopathies.
|
Transfus Apher Sci
|
2010
|
0.77
|
|
259
|
Mesenchymal stromal cell infusions as rescue therapy for corticosteroid-refractory adult autoimmune enteropathy.
|
Mayo Clin Proc
|
2012
|
0.77
|
|
260
|
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host.
|
Clin Immunol
|
2010
|
0.77
|
|
261
|
Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
|
Exp Hematol
|
2005
|
0.77
|
|
262
|
Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic stem cell transplant in children: results of a prospective randomized trial.
|
Haematologica
|
2002
|
0.77
|
|
263
|
Drug Transporters and Multiple Drug Resistance in Pediatric Solid Tumors.
|
Curr Drug Metab
|
2016
|
0.77
|
|
264
|
Role of a hematopoietic stem cell transplant registry in childhood: the experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
|
Haematologica
|
2002
|
0.76
|
|
265
|
Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy.
|
Int J Oncol
|
2012
|
0.76
|
|
266
|
Programming a hematopoietic stem cell donor: the evolution of a project over time.
|
Haematologica
|
2006
|
0.76
|
|
267
|
Transplantation and innate immunity: the lesson of natural killer cells.
|
Ital J Pediatr
|
2009
|
0.76
|
|
268
|
In vivo T-cell depletion with pretransplant low-dose antithymocyte globulin is associated with reduced transplant-related mortality and improved clinical outcome in patients receiving allogeneic hematopoietic stem cell transplantation from unrelated and partially matched related donors.
|
Am J Hematol
|
2010
|
0.76
|
|
269
|
Epigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectives.
|
Int J Mol Sci
|
2012
|
0.76
|
|
270
|
Innovative approaches to hematopoietic stem cell transplantation for patients with thalassemia.
|
Haematologica
|
2005
|
0.76
|
|
271
|
A registry of HLA-typed donors for production of virus-specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune-compromised patients.
|
Transfusion
|
2014
|
0.76
|
|
272
|
Effect of methylprednisolone in patients with Guillain-Barré syndrome.
|
Lancet
|
2004
|
0.75
|
|
273
|
Chromosome anomalies in bone marrow as primary cause of aplastic or hypoplastic conditions and peripheral cytopenia: disorders due to secondary impairment of RUNX1 and MPL genes.
|
Mol Cytogenet
|
2012
|
0.75
|
|
274
|
Spinal osteomyelitis due to Aspergillus flavus in a child: a rare complication after haematopoietic stem cell transplantation.
|
Pediatr Radiol
|
2008
|
0.75
|
|
275
|
Quantitative ultrasound detects bone impairment after bone marrow transplantation in children and adolescents affected by hematological diseases.
|
Bone
|
2008
|
0.75
|
|
276
|
Chronic graft-versus-host disease after reduced-intensity stem cell transplantation versus conventional hematopoietic stem cell transplantation.
|
Hematology
|
2005
|
0.75
|
|
277
|
Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission.
|
J Pediatr Hematol Oncol
|
2008
|
0.75
|
|
278
|
Report of a child with vitiligo and Evans syndrome.
|
J Pediatr Hematol Oncol
|
2003
|
0.75
|
|
279
|
Vitiligo-like lesions and diffuse lightening of the skin in a pediatric patient treated with imatinib mesylate: a noninvasive colorimetric assessment.
|
Pediatr Dermatol
|
2006
|
0.75
|
|
280
|
Genetic prothrombotic factors in children with otogenic lateral sinus thrombosis: five case reports.
|
Blood Coagul Fibrinolysis
|
2012
|
0.75
|
|
281
|
Microscopic neoplastic thrombosis in localised nephroblastoma: does it influence outcome?
|
Eur J Cancer
|
2010
|
0.75
|
|
282
|
A refined approach to detect and measure minimal residual disease in childhood acute myeloid leukemia by flow cytometry.
|
Am J Hematol
|
2014
|
0.75
|
|
283
|
Non-myeloablative stem cell transplantation for severe combined immunodeficiency--Omenn syndrome.
|
Br J Haematol
|
2004
|
0.75
|
|
284
|
T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation.
|
Blood
|
2004
|
0.75
|
|
285
|
Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases.
|
Br J Haematol
|
2014
|
0.75
|
|
286
|
Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse?
|
Haematologica
|
2002
|
0.75
|
|
287
|
Efficacy and safety of recombinant urate oxidase (rasburicase) for treatment and prophylaxis of hyperuricemia in children undergoing chemotherapy.
|
Haematologica
|
2005
|
0.75
|
|
288
|
Prognostic value of donor cytotoxic T-lymphocyte precursor frequencies for acute graft-versus-host disease in hematopoietic stem cell transplantation from HLA-matched siblings: a single center experience in a cohort of 92 patients.
|
Haematologica
|
2006
|
0.75
|
|
289
|
Usefulness of 18F-FDG PET/CT in an unusual case of solid-pseudopapillary pancreatic tumor in childhood with aggressive behavior.
|
Clin Nucl Med
|
2013
|
0.75
|
|
290
|
Non-radiolabelled PCR consensus primers and automatic sequencing enable rapid identification of tumor-specific V(H) CDR3 in aggressive B-cell malignancies.
|
Leuk Lymphoma
|
2003
|
0.75
|
|
291
|
Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia.
|
Oncol Rep
|
2006
|
0.75
|
|
292
|
Foreword. New frontiers in molecular and cellular therapy.
|
Immunol Lett
|
2013
|
0.75
|
|
293
|
Chronic graft-versus-host disease and non-melanoma skin cancer in children: report of two cases.
|
Acta Derm Venereol
|
2008
|
0.75
|
|
294
|
Allogenic stem cell transplantation following non-myeloablative conditioning regimens as adoptive immunotherapy in patients with hematological malignancies.
|
Med Sci Monit
|
2002
|
0.75
|
|
295
|
A New Enzyme-Linked Immunosorbent Assay (Elisa) For A Total Anti-T Lymphocyte Globulin Determination: Development, Analytical Validation And Clinical Application.
|
Ther Drug Monit
|
2017
|
0.75
|
|
296
|
Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.
|
Pediatr Blood Cancer
|
2010
|
0.75
|
|
297
|
Acute hepatitis-like presentation of graft-versus-host disease following donor lymphocyte infusion.
|
Acta Haematol
|
2003
|
0.75
|